Bruce Rutherford
Directeur/Membre du Conseil chez Dentigenix, Inc.
Postes actifs de Bruce Rutherford
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Dentigenix, Inc.
 Dentigenix, Inc. BiotechnologyHealth Technology Dentigenix, Inc. develops tissue engineering, stem cell, and dental biological products. The company was founded by Christopher P. Somogyi on January 21, 2003 and is headquartered in Seattle, WA. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Bruce Rutherford
Anciens postes connus de Bruce Rutherford
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Dentigenix, Inc.
Dentigenix, Inc. BiotechnologyHealth Technology Dentigenix, Inc. develops tissue engineering, stem cell, and dental biological products. The company was founded by Christopher P. Somogyi on January 21, 2003 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Novalar Pharmaceuticals, Inc.
 Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2006 | - |
Formation de Bruce Rutherford
| University of Washington | Undergraduate Degree |
| Rochester Christian University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | Health Technology |
Dentigenix, Inc.
Dentigenix, Inc. BiotechnologyHealth Technology Dentigenix, Inc. develops tissue engineering, stem cell, and dental biological products. The company was founded by Christopher P. Somogyi on January 21, 2003 and is headquartered in Seattle, WA. | Health Technology |
- Bourse
- Insiders
- Bruce Rutherford
- Expérience
